Literature DB >> 11588513

Women's willingness to participate in microbicide trials in Northern Thailand.

K Tharawan1, C Manopaiboon, C Ellertson, K Limpakarnjanarat, S Chaikummao, P H Kilmarx, K Blanchard, C Coggins, T D Mastro, C Elias.   

Abstract

To assess women's interests and concerns regarding participation in trials of microbicides in Chiang Rai, Thailand, we administered structured questionnaires. Before answering the questionnaire, women attended an educational session on microbicides and clinical trials. Of 370 participants, 82% correctly answered 8 or more of the 11 overall comprehension questions, indicating an adequate knowledge base among the women from which to answer questions about attitudes toward microbicide trials. The most common motivations for participating in a trial were "getting tested for HIV" and "doing something good for women's health." The greatest barrier to participation was women's fear that if they proposed use of a microbicide, their husbands might feel protected and thereby have more sex partners. Overall, 6.2% said they would be "definitely willing to participate," and 66.8% said they wanted to participate but wanted to think about it. Most women previously unacquainted with the concept of microbicides or clinical trial design displayed adequate knowledge of these subjects after the short educational session. If women's initial reactions are validated by actual willingness, surveys could prove valuable for selecting sites for microbicide trials, estimating enrollment rates, and tailoring trials to make them most acceptable to women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588513     DOI: 10.1097/00126334-200110010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

1.  Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India).

Authors:  Waimar Tun; Lauren L Katzen; Sharon A Abbott; Aylur K Srikrishnan; Christine A Kelly; Avina Sarna; Barbara A Friedland; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2015-02

2.  The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.

Authors:  Rebecca Giguere; Gregory D Zimet; Jessica A Kahn; Curtis Dolezal; Cheng-Shiun Leu; Marina Mabragaña; Ian McGowan; Alex Carballo-Diéguez
Journal:  World J AIDS       Date:  2013-09

3.  Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.

Authors:  Barbara S Mensch; Barbara A Friedland; Sharon A Abbott; Lauren L Katzen; Waimar Tun; Christine A Kelly; Avina Sarna; Aylur K Srikrishnan; Suniti Solomon
Journal:  AIDS Behav       Date:  2013-02

4.  Australian men's experiences during a microbicide male tolerance study.

Authors:  Susan L Rosenthal; Wendy Holmes; Lisa Maher
Journal:  AIDS Care       Date:  2009-01

5.  'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa.

Authors:  Catherine Macphail; Sinead Delany-Moretlwe; Philippe Mayaud
Journal:  Patient Prefer Adherence       Date:  2012-08-14       Impact factor: 2.711

6.  The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.

Authors:  Joyce L Browne; Connie O Rees; Johannes J M van Delden; Irene Agyepong; Diederick E Grobbee; Ama Edwin; Kerstin Klipstein-Grobusch; Rieke van der Graaf
Journal:  Trop Med Int Health       Date:  2019-01-08       Impact factor: 2.622

7.  'What do I know? Should I participate?' Considerations on participation in HIV related research among HIV infected adults in Bangalore, South India.

Authors:  Rashmi J Rodrigues; Jimmy Antony; Shubha Krishnamurthy; Anita Shet; Ayesha De Costa
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

8.  Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.

Authors:  Ariana W K Katz; Barbara S Mensch; Kubashni Woeber; Petina Musara; Juliane Etima; Ariane van der Straten
Journal:  BMC Womens Health       Date:  2019-01-25       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.